Cosman, Felicia, 1958-
Combination and sequential therapy for the treatment of Osteoporosis [electronic resource] / Felicia Cosman. - London : Henry Stewart Talks, 2015. - 1 online resource (1 streaming video file (22 min.) : color, sound). - Bone in health and disease : bone physiology and osteoporosis, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Bone in health and disease. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Current pharmacologic management of osteoporosis -- Choosing anabolic vs. antiresorptive therapy -- The PaTH trial -- Response to teriparatide (TPTD) -- Evaluating combination and sequential therapy -- Zoledronic acid and daily TPTD study -- DATA trial (TPTD or denosumab monotherapy vs. combination) -- TPTD in naïve vs. treatment experienced women -- TPTD monotherapy vs. combination therapy -- TPTD after prior treatment (bisphosphonate, raloxifene or alendronate) -- Total hip BMD percent changes -- Switch to TPTD in patients on prior denosumab or antiresorptive treatment -- TPTD in treatment experienced (switch vs. add) -- Hip & spine strength and volumetric BMD -- CONFORS trial -- Bone turnover.
Access restricted to subscribers.
Mode of access: World Wide Web.
3879 Henry Stewart Talks
Chemotherapy, Combination.
Osteoporosis--Chemotherapy.
Osteoporosis--Treatment.
Antibodies, Monoclonal, Humanized--therapeutic use.
Bone Density Conservation Agents--therapeutic use.
Bone Density.
Diphosphonates--therapeutic use.
Drug Therapy, Combination.
Osteoporosis--drug therapy.
Raloxifene--therapeutic use.
Teriparatide--therapeutic use.
Combination and sequential therapy for the treatment of Osteoporosis [electronic resource] / Felicia Cosman. - London : Henry Stewart Talks, 2015. - 1 online resource (1 streaming video file (22 min.) : color, sound). - Bone in health and disease : bone physiology and osteoporosis, 2056-452X . - Henry Stewart talks. Biomedical & life sciences collection. Bone in health and disease. .
Animated audio-visual presentation with synchronized narration. Title from title frames.
Contents: Current pharmacologic management of osteoporosis -- Choosing anabolic vs. antiresorptive therapy -- The PaTH trial -- Response to teriparatide (TPTD) -- Evaluating combination and sequential therapy -- Zoledronic acid and daily TPTD study -- DATA trial (TPTD or denosumab monotherapy vs. combination) -- TPTD in naïve vs. treatment experienced women -- TPTD monotherapy vs. combination therapy -- TPTD after prior treatment (bisphosphonate, raloxifene or alendronate) -- Total hip BMD percent changes -- Switch to TPTD in patients on prior denosumab or antiresorptive treatment -- TPTD in treatment experienced (switch vs. add) -- Hip & spine strength and volumetric BMD -- CONFORS trial -- Bone turnover.
Access restricted to subscribers.
Mode of access: World Wide Web.
3879 Henry Stewart Talks
Chemotherapy, Combination.
Osteoporosis--Chemotherapy.
Osteoporosis--Treatment.
Antibodies, Monoclonal, Humanized--therapeutic use.
Bone Density Conservation Agents--therapeutic use.
Bone Density.
Diphosphonates--therapeutic use.
Drug Therapy, Combination.
Osteoporosis--drug therapy.
Raloxifene--therapeutic use.
Teriparatide--therapeutic use.